PP

Pericharlla Padmavathi

Active Director Director DIN 09234940
DIN 09234940 First appointment Jul 2021 Primary industry Research & Development
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Pericharlla Padmavathi

Data last updated:

Pericharlla Padmavathi is a Director at Leonurus Biological Private Limited (since 2021). The company operates in Research & Development.

DIN 09234940
Primary Designation Director
Industry Research & Development
First Appointment 10 Jul 2021
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Leonurus Biological Private Limited U73100TG2020PTC138303
Director10 Jul 20212020Active

Board colleagues of Pericharlla Padmavathi

NameDINCompanyDesignation
Kishore Varma Pericherlla08663202Leonurus Biological Private LimitedDirector

Directorship timeline

Open interactive timeline →
Leonurus Biological Private Limited
Premium access

Shareholding and investment profile for Pericharlla Padmavathi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pericharlla Padmavathi

Pericharlla Padmavathi currently holds 1 directorship: Leonurus Biological Private Limited (Director, since 10 Jul 2021).

Pericharlla Padmavathi was first appointed on 10 Jul 2021 as Director at Leonurus Biological Private Limited.

The current boards of Pericharlla Padmavathi's companies include Kishore Varma Pericherlla (Leonurus Biological Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available